A California court has delivered a mixed verdict in a patent dispute between Nevro Corp. and Boston Scientific Corp., upholding some of Nevro’s key patent claims even while ruling that Boston Scientific hadn’t infringed the patents in question.
Nevro’s patents cover technology used in nerve-stimulation devices for pain that the company says delivers a therapeutic effect without causing the tingling or discomfort associated with most nerve stimulation.In a July 24 ruling, Judge Vince Chhabria of the US District Court for Northern California determined that six claims across three Nevro patents were valid
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?